Alterations in evoked otoacoustic emissions by the use of meglumine antimoniate in american tegumentary leishmaniasis patients
- Autores: Carvalho de Castro E, de Araújo-Melo MH, de Oliveira Schubach A, de Vasconcellos Carvalhães Oliveira R, do Nascimento Brahim Paes LR, Jardim Duarte CC, Oliveira Bezerra DC, Oliveira de Barcelos R, Pereira Bom Braga F, Ramos Ferreira Terceiro B, Salgado de Sousa Torraca T, Valete-Rosalino CM
- Ano de Publicação: 2017
- Journal: PLoS One
- Link: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0168492
Tegumentary Leishmaniasis (TL) is a neglected, non-contagious, infectious disease, caused by different protozoa species of the Leishmania genus that affects skin and mucous membranes. Meglumine Antimoniate (MA), the first drug of choice for TL treatment in Brazil, has already been associated with cochlear toxicity, which is defined as damages of the cochlea caused by exposure to chemical […]
Ler mais